These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35494328)

  • 21. The executive profile of children with Benign Epilepsy of Childhood with Centrotemporal Spikes and Temporal Lobe Epilepsy.
    Lima EM; Rzezak P; Guimarães CA; Montenegro MA; Guerreiro MM; Valente KD
    Epilepsy Behav; 2017 Jul; 72():173-177. PubMed ID: 28622557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive, psychiatric, and substance use characteristics in opioid dependent adults.
    Arias F; Arnsten JH; Cunningham CO; Coulehan K; Batchelder A; Brisbane M; Segal K; Rivera-Mindt M
    Addict Behav; 2016 Sep; 60():137-43. PubMed ID: 27131800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid drug utilization and cost outcomes associated with the use of buprenorphine-naloxone in patients with a history of prescription opioid use.
    Kaur AD; McQueen A; Jan S
    J Manag Care Pharm; 2008 Mar; 14(2):186-94. PubMed ID: 18331120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations.
    Larance B; Dietze P; Ali R; Lintzeris N; White N; Jenkinson R; Degenhardt L
    Drug Alcohol Rev; 2015 Nov; 34(6):603-10. PubMed ID: 25950232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment.
    Mokri A; Chawarski MC; Taherinakhost H; Schottenfeld RS
    Addiction; 2016 May; 111(5):874-82. PubMed ID: 26639678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Executive functioning in schizophrenia spectrum disorder patients and their unaffected siblings: a ten-year follow-up study.
    Sánchez-Torres AM; Basterra V; Moreno-Izco L; Rosa A; Fañanás L; Zarzuela A; Peralta V; Cuesta MJ
    Schizophr Res; 2013 Feb; 143(2-3):291-6. PubMed ID: 23265775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Working memory and affective decision-making in addiction: a neurocognitive comparison between heroin addicts, pathological gamblers and healthy controls.
    Yan WS; Li YH; Xiao L; Zhu N; Bechara A; Sui N
    Drug Alcohol Depend; 2014 Jan; 134():194-200. PubMed ID: 24268669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
    Scott TM; Arnsten J; Olsen JP; Arias F; Cunningham CO; Rivera Mindt M
    Addict Sci Clin Pract; 2021 Oct; 16(1):64. PubMed ID: 34689841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of executive function on emotion recognition and emotion experience in patients with schizophrenia.
    Lee SJ; Lee HK; Kweon YS; Lee CT; Lee KU
    Psychiatry Investig; 2009 Sep; 6(3):156-62. PubMed ID: 20046390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multi-site prescription opioid addiction treatment study: 18-month outcomes.
    Potter JS; Dreifuss JA; Marino EN; Provost SE; Dodd DR; Rice LS; Fitzmaurice GM; Griffin ML; Weiss RD
    J Subst Abuse Treat; 2015 Jan; 48(1):62-9. PubMed ID: 25189089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of retention in the treatment for opioid dependence: A prospective, observational study from India.
    Shouan A; Ghosh A; Singh SM; Basu D; Mattoo SK
    Indian J Psychiatry; 2021; 63(4):355-365. PubMed ID: 34456348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of euthymic bipolar patients with unaffected first-degree relatives and healthy controls in terms of neuropsychological functions.
    Civil Arslan F; Tiryaki A; Ozkorumak E
    Int J Psychiatry Clin Pract; 2014 Aug; 18(3):208-14. PubMed ID: 24164495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.
    Fiellin DA; Pantalon MV; Chawarski MC; Moore BA; Sullivan LE; O'Connor PG; Schottenfeld RS
    N Engl J Med; 2006 Jul; 355(4):365-74. PubMed ID: 16870915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a Mandated Change in Buprenorphine Formulation.
    Graddy R; Rastegar DA
    J Addict Med; 2017; 11(6):435-439. PubMed ID: 28742624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film.
    Gunderson EW; Sumner M
    J Addict Med; 2016; 10(2):124-30. PubMed ID: 26918662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism.
    Babińska D; Barczyński M; Stefaniak T; Osęka T; Babińska A; Babiński D; Sworczak K; Lachiński AJ; Nowak W; Sledziński Z
    Langenbecks Arch Surg; 2012 Jun; 397(5):825-31. PubMed ID: 22160326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies.
    Pirastu R; Fais R; Messina M; Bini V; Spiga S; Falconieri D; Diana M
    Drug Alcohol Depend; 2006 Jun; 83(2):163-8. PubMed ID: 16343811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.